The tumor-derived oncometabolite D-2-Hydroxyglutarate alters the immune phenotype as well as mitochondrial activity of monocyte-derived dendritic cells

Hammon, K. and Cardenas-Conejo, Z. E. and Dettmer, K. and Oefner, P. and Herr, W. and Renner, K. and Kreutz, M. and Thomas, S. (2017) The tumor-derived oncometabolite D-2-Hydroxyglutarate alters the immune phenotype as well as mitochondrial activity of monocyte-derived dendritic cells. ONCOLOGY RESEARCH AND TREATMENT, 40 (Suppl3). p. 190. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Institut für Funktionelle Genomik > Lehrstuhl für Funktionelle Genomik (Prof. Oefner)
Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Zentren des Universitätsklinikums Regensburg > Regensburger Centrum für Interventionelle Immunologie (RCI)
Depositing User: Petra Gürster
Date Deposited: 14 Dec 2018 13:15
Last Modified: 17 Sep 2020 06:28
URI: https://pred.uni-regensburg.de/id/eprint/1259

Actions (login required)

View Item View Item